
Check-Cap Ltd. CHEK
Annual report 2024
added 04-11-2026
Check-Cap Ltd. EBITDA per Share 2011-2026 | CHEK
Annual EBITDA per Share Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.41 | -3.26 | -3.46 | -4.11 | -8.97 | -1.75 | - | -0.01 | -7.39 | -12.5 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.01 | -12.5 | -5.09 |
Quarterly EBITDA per Share Check-Cap Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | -0.06 | - | - | - | -0.13 | - | - | - | -0.42 | - | - | - | -0.71 | - | - | - | -2 | - | - | - | -0.15 | - | - | - | -194 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.06 | -194 | -28.2 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
5.49 | $ 118.56 | -1.01 % | $ 36 B | ||
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 21.73 | 5.69 % | $ 234 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 525.86 | 1.41 % | $ 15.2 B | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 22.35 | 27.21 % | $ 1.19 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
-0.62 | $ 8.15 | -6.16 % | $ 1.04 B | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.2 | -2.39 % | $ 2 B | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
0.61 | $ 28.87 | -0.76 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 1.46 | 2.82 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 24.42 | -0.81 % | $ 678 M | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 6.79 | -1.59 % | $ 283 M | ||
|
Soleno Therapeutics
SLNO
|
0.22 | $ 52.59 | 0.03 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
-0.42 | $ 1.39 | -0.36 % | $ 91.7 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 180.18 | -0.21 % | $ 8.93 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 519.83 | -2.23 % | $ 196 B | ||
|
Danaher Corporation
DHR
|
7.63 | $ 194.25 | -1.96 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 2.2 | - | $ 9.73 M | ||
|
Trinity Biotech plc
TRIB
|
0.08 | $ 0.69 | -1.42 % | $ 61.9 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 56.23 | -2.41 % | $ 3.36 B | ||
|
Illumina
ILMN
|
-3.01 | $ 131.79 | -0.36 % | $ 21 B | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 16.13 | -0.25 % | $ 488 M | ||
|
Guardant Health
GH
|
-3.17 | $ 84.99 | 0.15 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-361 | $ 2.81 | -4.09 % | $ 91.2 K | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.19 | 4.03 % | $ 5.03 M | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 118.16 | 1.42 % | $ 9.75 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 268.19 | 0.48 % | $ 22.3 B | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
6.02 | $ 321.65 | -1.4 % | $ 19.2 B | ||
|
Celcuity
CELC
|
-3.68 | $ 124.49 | 0.82 % | $ 5.82 B | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 5.1 | -1.76 % | $ 472 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 82.61 | -1.58 % | $ 5.58 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 192.76 | 0.7 % | $ 21.4 B |